# Aignosis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aignosis

- Industry: Healthcare
- Headquarters: Jaipur, India
- Website: www.aignosis.in/
- Total disclosed funding: $0.4M
- Latest round: Seed (Oct 1, 2026)
- Investors on record: 2

## About

Based in Jaipur, India, and founded in 2024, Aignosis develops AI-driven solutions for the early screening and detection of autism in children using computer vision and machine learning, enabling non-invasive and affordable screening through standard webcams. The company was co-founded by Raksheet Jain and Divyansh Mangal. In October 2026, the company raised INR 40 million in seed funding from Antler and IIMA Ventures.

The company offers an AI-based autism screening platform that analyzes behavioral biomarkers such as eye movement, attention patterns, and facial responses from short video interactions. The solution delivers screening results within minutes and is intended to support clinicians and caregivers in identifying children who may require further clinical evaluation.

Aignosis generates revenue through paid autism screening services offered to clinics, institutions, and caregivers. Its model is centered on providing low-cost, scalable access to early screening tools within the healthcare ecosystem.

## Funding rounds

- Seed, Oct 1, 2026, $0.4M — IIMA Ventures, Antler

## Investors

- IIMA Ventures (https://capitalatlas.ai/funds/iima-ventures) — Seed
- Antler (https://capitalatlas.ai/funds/antler) — Seed